1 / 1
Pacritinib(Vonjo)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
BIOVITRUM AB
Formulation:
CAPSULE
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Vonjo(Pacritinib) Instructions:Uses,Dosage, Side Effects
VONJO (pacritinib) is a prescription kinase inhibitor supplied as 100 mg capsules. It is characterized by its distinct mechanism of action, which selectively targets key kinases like JAK2, FLT3, and IRAK1 without inhibiting JAK1. This profile positions it as a specialized therapeutic option for managing myelofibrosis in adults presenting with significant thrombocytopenia, a condition where treatment choices are often limited.
